BioCentury

10:58 PM GMT, Sep 21, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Top Story

Vivus falls on expected CHMP negative opinion

Vivus Inc. (NASDAQ:VVUS) fell $2.72 (11%) to $21 on Friday after the company said it expects EMA's CHMP to

Read the full 193 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.